Logo
RABIES ANTISERUM MARKET ANALYSIS
  2. / Market Insights
  3. Rabies Antiserum Market Analysis
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

RABIES ANTISERUM MARKET ANALYSIS

Rabies Antiserum Market, By Type (Monoclonal Antibodies (mAbs), Polyclonal Antibodies), By Application (Pre-Exposure Prophylaxis (PrEP), Post-Exposure Prophylaxis (PEP)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Nov 2023
  • Code : CMI5711
  • Pages :155
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market News

Recent Developments

New product launches

  1. In April 2020, Grifols, a leading global producer of plasma-derived medicines, announced the launch of a new 3-mL (900-IU) vial for HyperRAB (rabies immune globulin [human]), a treatment for rabies postexposure prophylaxis.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.